Locoregionally recurrent breast cancer: Incidence, risk factors and survival

Cancer Treatment Reviews

Volumn 27, Issue 2, 2001, Pages 67-82

  Clemons, M ^a,b   Danson, S ^a   Hamilton, T ^b   Goss, P ^b  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Breast cancer; Locoregional recurrence

Indexed keywords

ANTINEOPLASTIC AGENT;

AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER INCIDENCE; CANCER RECURRENCE; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; EARLY CANCER; FEMALE; HUMAN; LYMPH NODE DISSECTION; MASTECTOMY; METASTASIS; PREMENOPAUSE; PROGNOSIS; REVIEW; RISK FACTOR; TUMOR LOCALIZATION; TUMOR VOLUME;

EID: 0034986267     PISSN: 03057372     EISSN: None     Source Type: Journal    
DOI: 10.1053/ctrv.2000.0204     Document Type: Review

References (258)

1. Clinical trials in malignant disease. Part III-Breast cancer; evaluation of post-operative radiotherapy
2. Postoperative radiotherapy in breast cancer-long-term results from the Oslo study
3. The effect of post-operative radiotherapy in breast cancer
4. Ten-year experience with CMG-based chemotherapy in resectable breast cancer
5. A randomized prospective trial of radical (Halsted) mastectomy versus modified radical mastectomy in 311 breast cancer patients
6. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation
7. The combination of radiotherapy, adjuvant chemotherapy (cyclophosphamide-doxorubicin-ftorafur) and tamoxifen in stage II breast cancer. Long-term follow-up results of a randomised trial
8. Local control and survival in early breast cancer: The Milan trial
9. The significance of local control in the primary treatment of breast cancer. Lucy Wortham James clinical research award
10. The efficacy of delayed radiotherapy for locoregionally recurrent postmastectomy breast cancer
11. Role of radiotherapy following total mastectomy in patients with early breast cancer
12. Randomised trial of chemo-endocrine therapy, endocrine therapy, and mastectomy alone in postmenopausal patients with operable breast cancer and axillary node metastasis
13. Endocrine adjuvant therapy for breast cancer
14. Ten-year results from the National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trial evaluating the use of L-phenylalanine mustard (L-PAM) in the management of primary breast cancer
15. Adequate locoregional treatment for early breast cancer may prevent secondary dissemination
16. Radiotherapy, chemotherapy, and tamoxifen as adjuncts to surgery in early breast cancer: A summary of three randomized trials
17. The total incidence of loco-regional recurrence in a randomized trial of breast cancer TNM stage II
18. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer
19. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer
20. Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM cancer
21. Results of the National Cancer Institute early breast cancer trial
22. Eight-year results of a prospective non-randomised study on therapy of small breast cancer
23. Danish randomized trial comparing breast conservation therapy with mastectomy: Six years of life-table analysis
24. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer
25. Conservative treatment versus mastectomy in early breast cancer: Patterns of failure with 15 years of follow-up data
26. Adjuvant postoperative radiotherapy, chemotherapy, and immunotherapy in stage III breast cancer, II. 5-year results and influence of levamisole
27. Adjuvant radiotherapy and chemotherapy in breast cancer
28. The 5-year results of a randomized trial of adjuvant radiation therapy after chemotherapy in breast cancer patients treated with mastectomy
29. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial
30. Adjuvant chemoimmunotherapy following regional therapy for isolated recurrences of breast cancer (stage IV NED)
31. A randomized trial of chemotherapy (L-PAM vs CMF) and irradiation for node positive breast cancer. Eleven year follow-up of a Piedmont Oncology Association trial
32. Postsurgical adjuvant chemotherapy with or without radiotherapy in women with breast cancer and positive axillary nodes: A South-Eastern Cancer Study Group (SEG) Trial
33. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer
34. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy
35. Sector resection with or without postoperative radiotherapy for stage I breast cancer: Five-year results of a randomized trial
36. Radiotherapy after breast-preserving surgery in women with localized cancer of the breast
37. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: An update
38. Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer
39. Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: Eight-year results from National Surgical Adjuvant Breast and and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracil
40. High local recurrence risk after breast-conserving therapy in node-negative premenopausal breast cancer patients is greatly reduced by one course of perioperative chemotherapy
41. Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial
42. The importance of the resection margin in conservative surgery for breast cancer
43. Analysis of failures following local treatment of isolated local-regional recurrence of breast cancer
44. Ipsilateral breast tumor recurrence as a predictor of distant disease: Implications for systemic therapy at the time of local relapse
45. Natural history of small breast cancers
46. Pattern of spread and progression in relation to the characteristics of the primary tumour in human breast cancer
47. Pattern of dissemination and survival following isolated locoregional recurrence of breast cancer. A prospective study with more than 10 years of follow up
48. Survival and pattern of failure following locoregional recurrence of breast cancer
49. Prognostic factors for survival after breast conserving therapy for stage I and II breast cancer. The role of local recurrence
50. The return of postmastectomy radiotherapy
51. Natural history of human breast cancer: Recent data and clinical implications
52. Local recurrences and distant metastases after conservative breast cancer treatments: Partly independent events
53. Subsequent sites of recurrence in patients with local, regional and soft tissue relapse: An analysis on 1217 cases
54. Local-regional breast cancer recurrence following mastectomy
55. Effect of systemic adjuvant treatment on first sites of breast cancer relapse
56. Ipsilateral breast tumor recurrence and survival following lumpectomy and irradiation: Pathological findings from NSABP protocol B-06
57. Local-regional recurrence after mastectomy or breast conserving therapy
58. Prognosis following local or regional recurrence after conservative surgery and radiotherapy for early stage breast carcinoma
59. Frequency, sites of relapse, and outcome of regional node failures following conservative surgery and radiation for early breast cancer
60. Local recurrence after breast-conserving surgery and radiotherapy. Frequency, time course, and prognosis
61. Prognostic significance of breast relapse after conservative treatment in node-negative early breast cancer
62. Ipsilateral breast tumor recurrence postlumpectomy is predictive of subsequent mortality: Results from a randomized trial
63. Factors associated with local breast cancer recurrence after lumpectomy alone
64. Reoperation for locally recurrent breast cancer in patients previously treated with conservative surgery
65. Cal. Locoregional recurrences following radical external beam irradiation and interstitial implantation for operable breast cancer-a twenty three year experience
66. Prognosis following salvage mastectomy for recurrence in the breast after conservative surgery and radiation therapy for early-stage breast cancer
67. Outcome of treatment for ipsilateral breast tumor recurrence in early-stage breast cancer
68. Analysis of local-regional relapses in patients with early breast cancers treated by excision and radiotherapy: Experience of the Institut Gustave-Roussy
69. Survival from first recurrence: Relative importance of prognostic factors in 1,015 breast cancer patients
70. Total mastectomy is not always mandatory for the treatment of recurrent breast cancer after lumpectomy alone
71. Local failure and margin status in early-stage breast carcinoma treated with conservation surgery and radiation therapy
72. Postmastectomy radiotherapy: Randomized trials
73. Uncontrolled local recurrence after treatment of breast cancer with breast conservation
74. Risk factors in breast-conservation therapy
75. Factors associated with local recurrence as a first site of failure following the conservative treatment of early breast cancer
76. Results of salvage mastectomy for local recurrence after breast-conserving surgery without radiation therapy
77. Breast conservation therapy for invasive breast cancer in Hong Kong: Factors affecting recurrence and survival in Chinese women
78. Breast cancer. Experiences with conservation therapy
79. Survival from first recurrence: Relative importance of prognostic factors in 1,015 breast cancer patients
80. Tamoxifen with and without radiation after partial mastectomy in patients with involved nodes
81. Local and distant recurrence after conservative management of "very low-risk" breast cancer are dependent events: A 10-year follow-up
82. Factors influencing local recurrence of cancer after partial mastectomy
83. Local relapse and contralateral tumor rates in patients with breast cancer treated with conservative surgery and radiotherapy (Institut Gustave Roussy 1970-1982)
84. Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant tamoxifen alone: Patterns of recurrence
85. Prognostic factors of breast recurrence in the conservative management of early breast cancer: A 25-year follow-up
86. Skin recurrences after breast-conserving therapy for early-stage breast cancer
87. Quadrantic excision and axillary node dissection without radiation therapy: The long-term results of a selective policy in the treatment of stage I breast cancer
88. An analysis of age and family history on outcome after breast-conservation treatment the University of Pennsylvania experience
89. Is breast-conserving surgery with radiation superior to mastectomy in selected patients?
90. Time course and prognosis of local recurrence following primary radiation therapy for early breast cancer
91. Local recurrence in the conservatively treated breast cancer patient: A correlation with age and family history
92. Should multicentric disease be an absolute contraindication to the use of breast-conserving therapy?
93. Partial mastectomy without radiation therapy
94. Mammographic pathologic, and treatment-related factors associated with local recurrence in patients with early-stage-breast cancer treated with breast conserving therapy
95. Breast conservation treatment of early stage breast cancer: Patterns of failure
96. Ctors influencing local recurrence after excision and radiotherapy for primary breast cancer
97. Prognostic implications of age in breast cancer patients treated with tumorectomy and irradiation or with mastectomy
98. Segmental mastectomy without radiotherapy for T1 and small T2 breast carcinomas
99. Salvage radiotherapy for local failures of lumpectomy and breast irradiation
100. Factors affecting recurrence in lumpectomy without irradiation for breast cancer
101. Isolated axillary recurrences after conservative treatment of breast cancer
102. Pathological factors predictive of local recurrence in patients with invasive breast cancer treated by conservative surgery and radiation therapy
103. Margin status and local recurrence after breast-conserving surgery
104. Local control of operable breast cancer after radiotherapy alone
105. Oestrogen receptor status predicts local recurrence following breast conservation surgery for early breast cancer
106. Local recurrence after breast conservation therapy for early stage breast carcinoma: Detection, treatment, and outcome in 266 patients
107. Relapse of breast cancer after adjuvant treatment in premenopausal and perimenopausal women: Patterns and prognoses
108. Local recurrences in patients with breast cancer at the North Carolina Memorial Hospital (1970-1982)
109. The clinical significance of skin recurrence after radical mastectomy in women with cancer of the breast
110. Editorial comment on "the link between local recurrence and distant metastasis in human breast cancer" by Serge Koscielny and Maurice Tubiana
111. Breast cancer: Relationship between the size of the primary tumour and the probability of metastatic dissemination
112. Locally recurrent carcinoma of the breast. Results of radiation therapy
113. The use of raditherapy for treatment of isolated locoregional recurrence of breast carcinoma after mastectomy
114. 3rd. Isolated local-regional recurrence following mastectomy for adenocarcinoma of the breast treated with radiation therapy alone or combined with surgery and/or chemotherapy
115. Prognosticators in recurrent breast cancer. A 15-year experience with irradiation
116. Management of locoregional recurrent breast cancer
117. Adjuvant radiation therapy versus surgery alone in operable breast cancer: Long-term follow-up of a randomized clinical trial
118. A preliminary assessment of factors associated with recurrent disease in a surgical adjuvant clinical trial for patients with breast cancer with special emphasis on the aggressiveness of therapy
119. The effect of adjuvant radiotherapy on the time of occurrence and prognosis of local recurrence in primary operable breast cancer
120. Low risk of locoregional recurrence of primary breast carcinoma after treatment with a modification of the Halsted radical mastectomy and selective use of radiotherapy
121. Loco-regional recurrence following mastectomy for early breast carcinoma: Efficacy of radiotherapy at the time of recurrence
122. Local recurrence in breast cancer: Implications for systemic disease
123. Locally recurrent breast carcinoma: The effect of adjuvant chemotherapy on prognosis
124. The influence of untreated internal mammary metastases upon the course of mammary cancer
125. Long-range results for breast cancer patients treated by radical mastectomy and postoperative radiation without adjuvant.chemotherapy: An update
126. Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy
127. A close or positive margin after mastectomy is not an indication for chest wall irradiation except in women aged fifty or younger
128. Adjuvant chemo-endocrine therapy or endocrine therapy alone for postmenopausal patients: Ludwig Studies III and IV
129. Costs and benefits of adjuvant therapy in breast cancer: A quality-adjusted survival analysis
130. Locally recurrent breast cancer after 'radical' surgery
131. Significance of local recurrence after mastectomy for breast cancer
132. Combined surgery and radiation therapy versus surgery alone in primary mammary carcinoma. I. The effect of orthovoltage radiation
133. Chemo- or endocrine adjuvant therapy alone or combined in postmenopausal patients (GABG Trial 1)
134. Radical mastectomy versus radical mastectomy plus internal mammary dissection. Five-year results of an international cooperative study
135. Is it useful to remove internal mammary nodes in operable breast cancer?
136. Predictors of recurrence for patients with small (one centimeter or less) localized breast cancer (T1a, b N0 M0)
137. Primary breast cancer treatments: A locoregional recurrence review
138. Patterns of recurrence and relapse-Anglo-Japanese comparative study
139. West Midlands Oncology Association trials of adjuvant chemotherapy in operable breast cancer: Results after a median follow-up of 7 years. I. Patients with involved axillary lymph nodes
140. Evaluation of radiotherapy in high-risk breast cancer patients
141. Prognostic factors at presentation and their relevance to the natural history of breast cancer
142. Patterns of tumor relapse following mastectomy and adjuvant systemic therapy in patients with axillary lymph node-positive breast cancer. Impact of clinical, histopathologic, and flow cytometric factors
143. Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation
144. Local-regional failure in patients treated with adjuvant chemotherapy for breast cancer
145. Locally recurrent cancer after radical mastectomy
146. Local-regional recurrence in breast cancer after mastectomy and adriamycin-based adjuvant chemotherapy: Evaluation of the role of postoperative radiotherapy
147. Elective irradiation with the electron beam after mastectomy for breast cancer
148. A randomized trial of five and three drug chemotherapy and chemoimmunotherapy in women with operable node positive breast cancer
149. Adjuvant chemohormonal therapy with cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP) or CMFP plus tamoxifen compared with CMF for premenopausal breast cancer patients
150. The significance of recurrence in breast cancer
151. Long-term results of post-operative radiation therapy following mastectomy with or without chemotherapy in stage I-III breast cancer
152. Salvage treatment of patients suffering relapse after adjuvant CMF chemotherapy
153. Locoregional recurrences after 649 modified radical mastectomies: Incidence and significance
154. Local or regionally recurrent carcinoma of the breast: Results of therapy in 121 patients
155. Breast recurrence following conservative surgery and radiation: Patterns of failure, prognosis, and pathologic findings from mastectomy specimens with implications for treatment
156. Internal mammary lymphadenopathy in breast carcinoma: CT appraisal of anatomic distribution
157. The prognostic significance of the supraclavicular lymph node metastases in breast cancer patients
158. Partial mastectomy without radiation is adequate treatment for patients with stages 0 and 1 carcinoma of the breast
159. Conservative surgery and radiotherapy for early-stage breast cancer using a lung density correction: The University of Michigan experience
160. Early breast cancer: Predictors of breast recurrence for patients treated with conservative surgery and radiation therapy
161. Ten-year results in 1070 patients with stages I and II breast cancer treated by conservative surgery and radiation therapy
162. Conservative treatment of early breast cancer. Long-term results of 1232 cases treated with quadrantectomy, axillary dissection, and radiotherapy
163. Local recurrence after breast-conserving therapy for invasive breast cancer: High incidence in young patients and association with poor survival
164. Results of breast conserving therapy for early breast cancer and the role of mammographic follow-up
165. Conservative treatment for breast cancer: Long-term results (15 years)
166. Analysis of local-regional relapses in patients with early breast cancers treated by excision and radiotherapy: Experience of the Institut Gustave-Roussy
167. Predicting the rate and extent of locoregional failure after breast conservation therapy for early breast cancer
168. Breast cancer: A 21 year experience with conservative surgery and radiation
169. Breast conserving surgery for invasive breast cancer: Risk factors for ipsilateral breast tumor recurrences
170. Results of wide excision for mammary recurrence after breast-conserving therapy
171. Late breast recurrence after lumpectony and irradiation
172. The effect of young age on tumor recurrence in the treated breast after conservative surgery and radiotherapy
173. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer
174. Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy
175. How to predict the risk of local relapse in the preserved breast
176. The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy
177. The significance of the pathology margins of the tumor excision on the outcome of patients treated with definitive irradiation for early stage breast cancer
178. Risk factors for breast recurrence in premenopausal and postmenopausal patients with ductal cancers treated by conservation therapy
179. Adjuvant chemotherapy with and without tamoxifen in the treatment of primary breast cancer: 5-year results from the National Surgical Adjuvant Breast and Bowel Project Trial
180. Significance of ipsilateral breast tumour recurrence after lumpectomy
181. Women 35 years of age or younger have higher locoregional relapse rates after undergoing breast conservation therapy
182. Mammary recurrences in women younger than forty
183. Influence of infiltrating lobular histology on local tumor control in breast cancer patients treated with conservative surgery and radiotherapy
184. Tumor excision and radiotherapy as primary treatment of breast cancer. Analysis of patient and treatment parameters and local control
185. Analyzing prognostic factors in breast cancer using a multistate model
186. Is breast conservation after local recurrence feasible?
187. Regional nodal management and patterns of failure following conservative surgery and radiation therapy for stage I and II breast cancer
188. Predictors of local recurrence following excision alone for ductal carcinoma in situ
189. Factors associated with local recurrence of mammographically detected ductal carcinoma in situ in patients given breast-conserving therapy
190. A case-control studyon risk factors for local recurrences or distant metastases in breast cancer patients treated with breast-conserving surgery
191. rdentification of patients at high risk for local recurrence after conservative surgery and radiation therapy for stage I or II breast cancer
192. Randomized phase ill study comparing irradiation and hyperthemia with irradiation alone in superficial measurable tumors
193. Lumpectomy margins, rexcision, and local recurrence of breast cancer
194. Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: Influence of margin status and systemic therapy on local recurrence
195. Local and distant failures after limited surgery with positive margins and radiotherapy for node-negative breast cancer
196. Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant systemic therapy alone: Patterns of recurrence
197. Systemic therapy in patients with node-negative breast cancer. A commentary based on two National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials
198. Tamoxifen for early breast cancer: An overview of the randomised trials
199. Effect of time interval between breast-conserving surgery and radiation therapy on ipsilateral breast recurrence
200. Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: Results from the National Breast and Bowel Project B-16
201. Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclophosphamide regimen for the treatInent of primary breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project 8-22
202. L-phenylalanine mustard (L-PAM) in the management of primary breast cancer. An update of earlier findings and a comparison with those utilizing L-PAM plus 5-fluorouracil (5-FU)
203. Alternative multivariate modelling for time to local recurrence for breast cancer patients receiving a lumpectomy alone
204. Younger women with breast carcinoma have a poorer prognosis than older women
205. BRCA1/BRCA2 in breast-conserving therapy
206. BRCA1/BRCA2 germ-line mutations in locally recurrent breast cancer patients after lumpectomy and radiation therapy: Implications for breast-conserving management in patients with BRCA1/BRCA2 mutations
207. Biomarkers for local recurrence after breast-conservation-a nested case-control study
208. Why are local recurrences after breast-conserving therapy more frequent in younger patients?
209. Breast-conserving therapy in patients with an inherited susceptibility to breast cancer
210. Pathologic findings from the National Surgical Adjuvant Breast Project (NsABP) Protocol B-17. Futraductal carcinoma (ductal carcinoma in situ)
211. Mutant p53 protein overexpression in women with ipsilateral breast tumor recurrence following lumpectomy and radiation therapy
212. Evaluation of HER-2 neu oncoprotein expression as a prognostic indicator of local recurrence in conservatively treated breast cancer: A case-control study
213. Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer
214. A biostatistica! study of locally recurrent breast carcinoma
215. Cancer of the breast. Local and regional recurrence
216. Prognosis after breast recurrence following conservative surgery and radiotherapy in patients with node-negative breast cancer
217. Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis
218. Survival cafter first recurrence in breast cancer
219. The prognostic significance of late local recurrence after breast-conserving therapy
220. The relationship between local relapse and distant metastases revisited
221. Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: Further support about the concept of tumor dormancy
222. Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: Experience of the Eastern Cooperative Oncology Group
223. Prognostic value of p53 for local failure in mastectomy-treated breast cancer patients
224. Biologic and clinicopathologic factors as indicators of specific relapse types in node-negative breast cancer
225. Natural history and prognosis of recurrent breast cancer
226. Importance of radiation therapy for breast cancer patients treated with high-dose dtemotherapy and stem cell transplant
227. The link betweep local recurrence and distant metastases in human breast cancer
228. Locoregional recurrence of breast cancer following mastectomy: Always a fatal event? Results of univariate and multivariate analysis
229. Analysis of prognostic factors in patients with isolated chest wall recurrence of breast cancer
230. The results of radiation therapy for isolated local regional recurrence after mastectomy
231. Frequency, anatomical distribution and management of local recurrences after definitive therapy for breast cancer
232. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases
233. Prognostic indicators in patients with isolated local-regional recurrence of breast Cancer
234. Detection of breast cancer local recurrences
235. Radiation therapy for 2 local-regional recurrent breast carcinoma
236. The significance of local recurrence of carcinoma of the breast
237. Age as a prognostic factor for breast and regional nodal recurrence following breast conserving surgery and irradiation in stage I and II breast cancer
238. Prognosis and treatment of loco-regional breast cancer recurrences: Critical considerations on 120 cases
239. Survival following locoregional recurrence of breast cancer; Univariate and multivariate analysis
240. Isolated local-regional recurrence of breast cancer following mastectomy: Radiotherapeutic management
241. Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials
242. Chest wall resection for locally recurrent breast cancer; is it worth-while?
243. Survival following local skin recurrence after mastectomy
244. Results of salvage surgery for mammary recurrence following breast-conserving therapy
245. Significance of estrogen and progesterone receptors, disease-free interval, and site of first metastasis on survival of breast cancer patients
246. The significance of supraclavicular fossa node recurrence after radical mastectomy
247. Dormancy of mammary carcinoma after mastectomy
248. Survival after recurrence of breast cancer
249. Recurrent breast cancer: Factors influencing survival, including treatment
250. Outcome of surgical resectign for chest wall recurrence in breast cancer patients
251. Survival after first recurrence of breast cancer. The Miami experience
252. Recurrence in the conserved breast: Why all this fuss about risk factors?
253. The natural history of human breast cancer. The relationship between involvement of axillary lymph nodes and the initiation of distant metastases
254. Local-regional treatment of patients with simultaneous local-regional recurrence and distant metastases following mastectomy
255. Management of locally recurrent breast cancer
256. The results of radiation therapy for isolated local regional recurrence after mastectomy